A New Approach for Sampling Ordered Parameters in Probabilistic Sensitivity Analysis by Ren, S. et al.
ORIGINAL RESEARCH ARTICLE
A New Approach for Sampling Ordered Parameters
in Probabilistic Sensitivity Analysis
Shijie Ren1 • Jonathan Minton2 • Sophie Whyte1 • Nicholas R. Latimer1 •
Matt Stevenson1
 The Author(s) 2017. This article is an open access publication
Abstract
Background Probabilistic sensitivity analysis (PSA) in
cost-effectiveness analysis involves sampling a large
number of realisations of an economic model. For some
parameters, we may be uncertain around the true mean
values of the variables, but the ordering of the values is
known. Typical sampling approaches lack either statistical
or clinical validity. For example, sampling using a common
number generator results in extreme dependence, and
independent sampling can lead to realisations with incor-
rect ordering.
Methods We propose a new sampling approach for ordered
parameters, the difference method (DM) approach, which
samples the parameters of interest via a difference
parameter. If the parameters of interest are bounded, it
involves transforming the variables so that they are
unbounded and then sampling via the difference parameter.
We have provided a Microsoft Excel workbook to imple-
ment the method. The proposed approach is illustrated with
an example sampling ordered parameters for utility and
cost.
Results The DM approach has a number of advantages
when comparing with the typical approaches used in
practice. It generates PSA samples that have similar sum-
mary statistics as the given values in our examples, while
maintaining the constraint that one value was greater than
another. The method also implies plausible positive cor-
relation between the two ordered variables.
Conclusions Both clinical and statistical validity should be
checked when producing PSA samples. The DM approach
should be considered as a solution to potential problems in
generating PSA samples for ordered parameters.
Key Points for Decision Makers
In health economic models, uncertain ordered
parameters are common. For example, utility and
treatment costs associated with different severity
levels of a disease are commonly ordered.
For ordered parameters, which are believed to be
related such that the value of one variable is always
greater than another, this information on ordering
should always be appropriately incorporated within
PSA.
The proposed sampling approach generates ordered
parameters with both clinical and statistical validity
for use in PSA.
1 Introduction
In health technology assessment, probabilistic sensitivity
analysis (PSA) represents the generally accepted approach
for characterising the uncertainty in parameters included in
an economic model and for producing accurate results in
non-linear models [1, 2]. This involves generating a large
Electronic supplementary material The online version of this
article (http://doi.org/10.1007/s40273-017-0584-3) contains supple-
mentary material, which is available to authorized users.
& Shijie Ren
s.ren@sheffield.ac.uk
1 University of Sheffield, Sheffield, UK
2 University of Glasgow, Glasgow, UK
PharmacoEconomics
DOI 10.1007/s40273-017-0584-3
number of realisations of the economic model, each time
sampling values from the distributions applied to each
uncertain parameter included in the model.
Sometimes there is an absolute belief that the value of
one variable is greater than the value of another. There may
be uncertainty around the true mean values of the variables,
but the ordering of the values is known. For example, if an
individual rates his/her general health as ‘good’, then later
as ‘fair’, we might be uncertain about how to map the
‘good’ and ‘fair’ health evaluations onto a numeric scale,
but can assume the ‘good’ general health score will be
higher than the ‘fair’ general health score. Health-related
quality of life (HRQoL) for two different severity levels of
a disease may also be related in this manner.
Failure to account for constraints between samples of
ordered parameters may result in PSA values that do not
accurately characterise the uncertainty present in a decision
problem. In theory, this could result in decisions made on
the allocation of scarce healthcare resources being subop-
timal, although the direction of bias would depend on the
specific model. Other outputs and analyses that are reliant
on the PSA, such as cost-effectiveness acceptability curves
(CEACs) and frontiers (CEAFs), and value of information
analyses, are likely to also be inaccurate if the constraint
that the value of one variable is greater than another is not
accounted for appropriately.
Based on the authors’ experience, as National Institute
for Health and Care Excellence (NICE) committee mem-
bers, Evidence Review Group members dealing with a
large number of NICE submissions every year, and peer
reviewers, we have identified multiple examples where
sampling of ordered parameters has not been handled
correctly. Independent sampling from the distributions of
the ordered parameters could result in a PSA that lacks
clinical validity as in some realisations the logical con-
straint may be violated, with the sampled value of
parameters potentially implying that having a disease
makes people healthier. We refer to this method as the
independent sampling approach. For example, in an NICE
Single Technology Appraisal [3] the use of the independent
sampling approach results in the utility in the progressed
state being higher than in the stable state. Another sam-
pling method used in practice used a common random
number to draw from both distributions [4], which induces
extreme dependence: one variable is a deterministic func-
tion of another. In addition to the extreme dependence
induced by this method, the sampled realisations of PSA
could still violate the known ordering if the cumulative
density functions of the two parameters cross. We refer to
this method as the common random number generator
approach. A flawed alternative observed in papers sent to
the authors for peer review is a method whereby samples
are excluded when the ordering assumption is violated. We
refer to this method as the modified independent sampling
approach. This approach results in the summary statistics
of the sampled realisations not equalling that of the source
data, and provides biased sampled realisations.
Typical approaches described above lack either statis-
tical or clinical validity. To have clinical validity when
sampling parameters where it is known that one value is
greater than another, all PSA realisations should exhibit the
logical order of the given parameters. To have statistical
validity, we have deemed that the following criteria should
be met: (1) if the parameters of interest are bounded then
all PSA realisations should be in these bounded ranges; (2)
the summary statistics of the sampled values of the
parameters of interest from PSA should match closely to
the given summary statistics of the parameters of interest;
(3) the induced correlation between the sampled values of
parameters of interest should be plausible.
Introducing an additional parameter that presents either
an absolute difference or a ratio of the ordered parameters
is a common approach for modelling the ordered parame-
ters explicitly. In Sect. 2, we apply this modelling idea in
generating samples for PSA, and propose a new approach
for sampling ordered parameters where summary statistics
have been provided for the parameters of interest. We call
this method the difference method (DM) approach. This
approach is illustrated with an example sampling ordered
parameters for utility and cost in Sect. 3, while Sect. 4
provides the results of comparing the performance of the
DM approach with the typical approaches used in practice.
Discussion is given in Sect. 5.
2 Methods
2.1 Unbounded Ordered Parameters
Suppose that there are two variables X and Y , where the
value of Y is greater than the value of X, the distribution of
X has mean lX and variance r
2
X , and the distribution of
Y has mean lY and variance r
2
Y . Let D denote the differ-
ence between X and Y , and l and r2 denote the mean and
variance of the distribution of the difference D, respec-
tively. The DM approach samples from either X and D or Y
and D, depending on the magnitude of the variances of X
and Y . If r2Y [ r
2
X , then define
Y ¼ X þ D ð1Þ
but if r2Y\r
2
X , then define
X ¼ Y  D: ð2Þ
Assuming X and D in Eq. 1 are independent, and Y and D
in Eq. 2 are independent, we get lY ¼ lX þ l and r2Y ¼
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r2X þ r2 from Eq. 1, and lX ¼ lY  l and r2X ¼ r2Y þ r2
from Eq. 2. Rearrange these equations, and we have l ¼
lY  lX and r2 ¼ r2Y  r2X



.
If both variable X and Y are unbounded, we propose
using a Gamma(s,r) distribution for D so that the difference
is always positive, where s is the shape parameter and r is
the rate parameter. Hence, l ¼ s
r
and r2 ¼ s
r2
. These can be
solved simultaneously to give
s ¼ l
2
r2
; ð3Þ
r ¼ l
r2
: ð4Þ
Other distributions with two model parameters for a
non-negative random variable such as log normal could
also be used, and will produce sampled realisations with
both clinical and statistical validity, but the induced
correlations might be different.
The sampling procedure depends on the magnitude of
the variances of X and Y .
• When r2Y [ r2X , it involves sampling X from Normal
(lX ,r
2
X) and D from Gamma (s,r). Sampled values of Y
are derived from sampled values of X and D using
Eq. 1.
• When r2Y\r2X , it involves sampling Y from Nor-
mal(lY ,r
2
Y ) and D from a Gamma(s,r). Sampled values
of X are derived from sampled values of Y and D using
Eq. 2.
The normal distribution is chosen because both X and Y
are unbounded and can take any values on the real line. In
addition, the input parameter of interest in an economic
model is typically the mean of a random variable, which is
approximately normally distributed because of the central
limit theorem. We have proposed to use a simulation
method to derive sampled values using either Eqs. 1 or 2;
however, an analytic solution might exist.
2.2 Bounded Ordered Parameters
If both X and Y are bounded between 0 and 1, such as
probabilities and most HRQoLs, or bounded to be positive,
such as cost, we suggest a four-step sampling procedure.
• Step 1: Given mean and variance of X and Y , sample X
and Y from Beta distributions if the X; Yð Þ 2 ½0; 1, and
sample from Gamma distributions if X; Yð Þ 2 ½0;1Þ.
The Gamma parameters can be derived using Eqs. 3
and 4. To derive the model parameter for a Beta
distribution given the mean and variance, let us assume
X is from a Beta(a; b) distribution. Hence
lX ¼
a
aþ b ;
r2X ¼
ab
aþ bð Þ2 aþ bþ 1ð Þ :
These two equations can be solved simultaneously to give
a ¼ 1 lXð ÞlX
r2X
 1
 
lX ; ð5Þ
b ¼ a 1 lX
lX
: ð6Þ
If Y is from a Betaða; bÞ, the Beta model parameters can
be derived using Eqs. 5 and 6 by replacing lX and r
2
X with
lY and r
2
Y .
• Step 2: Transform the sampled X and Y to the real line,
using X0 ¼ logit Xð Þ ¼ log X
1X
 
and Y 0 ¼ logit Yð Þ ¼
logð Y
1YÞ if the X; Yð Þ 2 ½0; 1; and using X0 ¼ logðXÞ
and Y 0 ¼ logðYÞ if the X; Yð Þ 2 ½0;1). Calculate the
mean and variance for sampled X0 and Y 0, where X0 and
Y 0 are the logit transformed X and Y if X; Yð Þ 2 ½0; 1,
and the log transformed X and Y if X; Yð Þ 2 ½0;1Þ.
• Step 3: Use the DM approach for unbounded variables
described in Sect. 2.1 to redefine D to be the difference
between X0 and Y 0. First, sample D from a Gamma
distribution, where the model parameters can be
derived using Eqs. 3 and 4. Then either using sampled
values for X0 from step 2 and sampled values for D to
derive sampled values for Y 0, or using sampled values
for Y 0 from step 2 and sampled values for D to derive
sampled values for X, depending on the magnitude of
the variance of X0 and Y 0.
• Step 4: Back transform sampled values for X0 and Y 0 to
obtain sampled values for X and Y . If X; Yð Þ 2 ½0; 1,
then use Y ¼ eY 0
1þeY 0 and X ¼ e
X0
1þeX0 . If X; Yð Þ 2 ½0;1),
then use X ¼ eX0 and Y ¼ eY 0 .
The logit or log transformation for the bounded X and Y
is to make sure that the sampled realisations will be in the
appropriate bounded range. Depending on the given sum-
mary statistics, some samples may fall outside of the
bounded ranges without the transformation.
3 Example
In this section, we illustrate how the proposed DM
approach can be implemented in a hypothetical example.
Suppose that there is an active (worse) and remission
(better) state in an economic model for a particular con-
dition. The input parameters are mean HRQoL and mean
cost. In health technology assessments, it is common that
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an analyst does not have access to the individual patient-
level data (IPD), but only summary statistics derived from
the IPD. For ordered parameters, often only the summary
statistics such as mean and standard deviation/variance for
each of the parameters are provided, but not the correlation
structure. Suppose that the analyst is given the following
information regarding the input parameters.
• Active (worse) state: the input parameter for HRQoL
(Xu) has mean lXu ¼ 0:54 and standard error 0.138
(variance r2Xu ¼ 0:019); the input parameter for cost
(Xc) has mean lXc ¼ 110 and standard error 3.872
(variance r2Xc ¼ 15).
• Remission (better) state: the input parameter for
HRQoL (Yu) has mean lYu ¼ 0:70 and standard error
0.126 (variance r2Yu ¼ 0:016); the input parameter for
cost (Yc) has mean lYc ¼ 100 and standard error 3.162
(variance r2Yc ¼ 10).
Suppose the analyst requires 5000 samples of realisa-
tions for each parameter in each state. It was known that
the HRQoL in the remission state is higher than the active
state, Yu[Xu, and HRQoL is bounded between 0 and 1,
Xu; Yuð Þ 2 ½0; 1. It was also known that the cost in the
remission state is lower than in the active state, Yc\Xc, and
cost is positive, Xc; Ycð Þ 2 ½0;1Þ. The four-step sampling
procedure for sampling mean HRQoL and mean cost is
given in Table 1.
For comparison, we also performed the independent
sampling approach, the modified independent sampling
approach, and the common random number generator
approach to sample mean HRQoL and mean cost in the
active and remission states. For the mean HRQoL param-
eters, the independent sampling approach generates Yu and
Xu by sampling Yu from Betað6:52; 5:55Þ and Xu from
Betað8:49; 3:64Þ independently. The modified independent
sampling approach samples independent realisations of Yu
and Xu first and then excludes the draws where the ordering
assumption is violated until it reaches the required number
of realisations. The common random number generator
approach samples Yu and Xu from the same Beta distribu-
tions as the other two approaches, but the same random
number generator was used for both parameters. For the
mean cost parameters, the distributions used in these three
standard sampling approaches were Gammað1000; 0:100Þ
and Gamma 806:67; 0:136ð Þ for Yc and Xc, respectively.
We also developed a Microsoft Excel workbook (Mi-
crosoft Corporation, Redmond, WA, USA) to implement
the DM approach, which is included as online supple-
mentary material to this paper (Online Resource 1). The
Microsoft Excel workbook used the example presented in
Sect. 3 for an illustration.
Table 1 Four-step sampling procedure for generating mean health-related quality of life and mean cost
Sampling procedure Sampling mean HRQoL Sampling mean cost
Step 1: Sample Y and X Sample 5000 values of Yu from Betað6:52; 5:55Þ and
5000 values of Xu from Betað8:49; 3:64Þ, where the
Beta distribution parameters were calculated using
Eqs. (5) and (6).
Sample 5000 values of Yc from Gammað1000; 0:100Þ
and 5000 values of Xc from Gammað806:67; 0:136Þ,
where the Gamma distribution parameters were
calculated using Eqs. (3) and (4).
Step 2: Transform sampled
Y and X from step 1 to
unbounded range
Transform sampled Yu and Xu from step 1 to unbounded
range using logit function: Y 0u ¼ logitðYuÞ and
X0u ¼ logitðXuÞ.
The mean and variance for the transformed variables are
l0Yu ¼ 0:928, r02Yu ¼ 0:436, l0Xu ¼ 0:186, and
r02Xu ¼ 0:364.
Transform sampled Yc and Xc from step 1 to unbounded
range using log function: Y 0c ¼ logðYcÞ and
X0c ¼ logðXcÞ.
The mean and variance for the transformed variables
are l0Yc ¼ 4:60, r02Yc ¼ 0:00101, l0Xc ¼ 4:70, and
r02Xc ¼ 0:00124.
Step 3: Sample the
difference between
transformed Y and X
Since r02Yu [r
02
Xu
, we define Y 0u ¼ X0u þ D0u, where the
mean and variance of D0u is 0.742 and 0.072,
respectively.
Sample D0u from Gammað7:64; 0:10Þ, where the Gamma
distribution parameters were calculated using Eqs. (3)
and (4). Compute sampled values of Y 0u by adding
sampled D0u and sampled X
0
u from step 2.
Since r02Yc\r
02
Xc
, we define X0c ¼ Y 0c þ D0c, where the
mean and variance of D0c is 0.10 and 0.0002,
respectively.
Sample D0c from Gammað41:07; 0:002Þ, where the
Gamma distribution parameters were calculated using
Eqs. (3) and (4). Compute sampled values of X0c by
subtracting sampled D0c from sampled Y
0
c from step 2.
Step 4: Back transform Back transform sampled Y 0u and X
0
u to Yu and Xu using
Yu ¼ eY
0
u
1þeY0u and Xu ¼
eX
0
u
1þeX0u .
Back transform sampled X0c and Y
0
c to Xc and Yc using
Xc ¼ eX0c and Yc ¼ eY 0c .
HRQoL health-related quality of life
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4 Results
Table 2 shows that the mean and variance of 5000 sampled
realisations using four sampling approaches (the DM,
independent sampling, modified independent sampling, and
common random number generator approaches). The
generated mean and variance of the sampled realisations
using all the approaches closely matched the given sum-
mary statistics, with the exception of the modified inde-
pendent sampling approach, which produces biased
sampled realisations and should be avoided in practice for
handling the logical problem in PSA. This method will
always underestimate the uncertainty in the ordered
parameters, overestimate the mean of the parameter with a
higher value, and underestimate the mean of the parameter
with a lower value. The magnitude of the bias depends on
the percentages of the sampled realisations that violated the
constraint. In the example, 20% of the sampled values in
5000 samples did not meet the logical order for the HRQoL
parameter, whereas 2% of the samples violated the order
for the cost parameter. The generated summary statistics
were closer to the given values for mean cost than mean
HRQoL.
The scatterplots of sampled pairs of values using the
three methods that produce unbiased sampled realisations
are provided in Fig. 1. These scatterplots show that the DM
approach guarantees to maintain the constraint that one
value is greater than another for each sampled pair, and
induced a positive correlation between the ordered vari-
ables. The independent sampling approach is likely to lack
both clinical and statistical validity since (1) it may pro-
duce a sampled value of mean HRQoL in the worse state
that is higher than the sampled value of mean HRQoL in
the better state (20% of the samples violated the order), and
a sampled value of mean cost in the better state that is
higher than the sampled value of mean cost in the worse
state (2% of the samples violated the order); and (2) there
are no correlations between the sampled realisations in the
two states. The common random number generator
approach is likely to lack statistical validity regarding the
correlations since this method implies that given the value
of one variable, the value of the other is fixed/determined,
i.e. two variables are perfectly correlated.
Using different sampling approaches in generating
samples for ordered parameters will have an impact on the
uncertainty of the incremental cost-effectiveness ratio
(ICER), and hence also the CEAC/CEAF; however, we
believe that this would rarely affect conclusions of policy.
Hence, we did not compare the methods based on the
change in uncertainty in ICER or CEAC/CEAF. Never-
theless, we should not stop improving the rigour of a
method just because it may not affect the conclusions.
5 Discussion
Sampling from ordered variables is a common task that an
analyst faces in conducting a PSA in cost-effectiveness
analysis (CEA). Given the summary statistics for the
ordered parameters, the only way to handle the logical
problem is by using an appropriate sampling approach in
the PSA. We have illustrated that typical approaches used
in practice, such as independent sampling, modified inde-
pendent sampling, and using a common random number
generator, lack either statistical or clinical validity. This
problem may only rarely affect conclusions or decisions
made based on economic evaluation results, but we believe
there is a need for a new sampling method to handle the
logical problem to improve the rigour of PSAs in CEA.
The proposed DM approach has been shown to be
effective in generating bivariate variables that satisfy both
clinical and statistical validity in the given examples. It
provides a solution to an issue that in theory may have
important implications for the interpretation of economic
evaluations of health technologies. An earlier version of the
method without the transformation step has been used in
recent work in health techonology assessment [5, 6], but
has been refined and made more generalisable in the pro-
cess of writing this paper.
When performing a PSA, often only the summary
statistics of the sampled realisations are compared with
their given values to check the statistical validity. We
Table 2 Mean and variance of 5000 sampled realisations using four sampling approaches
Variable Health
state
Given mean
(variance)
Generated mean (variance)
Difference
method
Independent
sampling
Modified independent
sampling
Common random
number
HRQoL Remission 0.70 (0.016) 0.70 (0.016) 0.70 (0.016) 0.73 (0.012) 0.70 (0.016)
Active 0.54 (0.019) 0.54 (0.019) 0.54 (0.019) 0.51 (0.016) 0.54 (0.020)
Cost Remission 100 (10) 100.02 (9.94) 100.02 (9.94) 99.9 (9.54) 100.02 (9.95)
Active 110 (15) 109.98 (15.29) 109.98 (15.10) 110.15 (13.87) 110.03 (14.93)
HRQoL health-related quality of life
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contend that when sampling from ordered variables, it is
also important to consider the clinical validity of the
induced correlations between the sampled values. If it is
believed that the ordered variables are neither independent
nor perfectly dependent, then the independent sampling
approach or the common random number generator
approach should be avoided. Assuming different paramet-
ric distributions in the proposed DM approach may result
in induced correlations of different magnitudes; whether
there is a best choice in specific scenarios is subject to
further research. The modified independent sampling
approach should be avoided in all cases because it produces
biased sampled realisations.
One limitation of this paper is that we have not con-
ducted a review of the methods used in handling the logical
problem in ordered parameters, and have only undertaken
one example to illustrate the properties of the proposed
method. One drawback of the DM approach is that it does
not work if utilities are believed to be below 0. A modi-
fication of the method is needed and this requires future
research. Some ordered parameters may have a multi-
plicative relationship rather than an additive. A multiplier
approach could be an alternative approach to handle the
logical problem. Assigning an appropriate distribution for
the multiplier parameter in PSA may be a challenge
because it may not have properties as convenient as those
in the difference parameter.
We have illustrated how the DM approach works in the
case of two ordered parameters. It can be extended to the case
of more than two ordered parameters by taking an iterative
approach of the proposed method. For example, if there are
three variables X; Y and Z, where the value of Z is greater
than the value of Y , and the value of Y is greater than the
value ofX, thenwe need to define two difference parameters:
D1 represents the difference between X and Y , and D2 rep-
resents the difference between Y and Z. We firstly sample X
and Y using the proposed DM approach, then apply the DM
approach again to sampled Y and D2 to derive samples for Z.
This logical problem of one variable being strictly
greater than another also exists in one-way sensitivity
analysis. The proposed method can be used in probabilistic
one-way sensitivity analysis to handle ordered parameters.
For deterministic one-way sensitivity analysis, making the
same change in the related variables will make sure the
parameter order remains unchanged; this ‘same change’
could either be relative (i.e. a multiple) or absolute (i.e. an
increment). This approach is similar to the common ran-
dom number generator approach in PSA.
Fig. 1 Scatterplots of pairs of
samples generated by three
methods: a for HRQoL, where
X is HRQoL in the disease-
active state and Y is HRQoL in
the disease-remission state;
b for cost, where X is cost in the
disease-remission state and Y is
cost in the disease-active state.
HRQoL health-related quality of
life, DM difference method, Ind
independent sampling method,
RN common random number
sampling method
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6 Conclusions
When producing PSA samples, both clinical and statistical
validity should be checked. Where there is a strong belief
that variables are constrained in that one value is greater
than another, the DM approach should be considered as a
method of ensuring the clinical and statistical validity of
PSA samples, and the analyses derived from these samples.
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